Search results
Research. My research is mainly focused on Alzheimer’s disease (AD) and other neurodegenerative diseases, but I also study acute brain injuries, e.g., after cardiac arrest, and the neurochemistry of other aspects of the brain, including regulation of pain and sleep.
Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia. S Janelidze, N Mattsson, S Palmqvist, R Smith, TG Beach, GE Serrano, ... Nature medicine 26 (3), 379-386. , 2020. 840.
Introduction. Medical doctor, specialist in clinical chemistry, resident in neurology. Previously post doc at UCSF. Main interests are Alzheimer's disease, neurodegeneration, and...
Feb 21, 2024 · Niklas Mattsson-Carlgren, Sebastian Palmqvist, Rik Ossenkoppele, Gil D. Rabinovici, Erik Stomrud, Randall J. Bateman & Oskar Hansson. Nature Medicine 30 , 1085–1095 ( 2024) Cite this article....
Principal investigator at MultiPark: Multidisciplinary research focused on Parkinson´s disease. Senior lecturer at WCMM-Wallenberg Centre for Molecular Medicine. Niklas Mattsson-Carlgren's profile in Lund University Research portal.
WCMM Fellow | Clinical Memory Research. Our research. Alzheimer’s disease (AD) is a common neurodegenerative disease, which causes immense suffering for tens of millions of patients and their relatives, and huge financial burdens for societies worldwide.
Niklas Mattsson is a European Patent Attorney specialising in life sciences. He has extensive experience in drafting and prosecuting patents and providing IP-related business advice. Contact information. Phone: +46 8 440 95 43. Mobile: +46 733 76 74 49. Email: niklas.mattsson@awa.com. Visiting address: Jakobsbergsgatan 36. 111 44 Stockholm, Sweden.
